CD86 - CD86 molecule Gene
Species: Oryctolagus cuniculus
Gene Type: protein coding
Gene ID: 100008999
CD86 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001082208.1 | NP_001075677.1 | T-lymphocyte activation antigen CD86 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
T-lymphocyte activation antigen CD86 |
|
Recombinant CD86 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72766 | B7-2/CD86 Protein, Rabbit (HEK293, His) | P42071 (A23-R246) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-N6664 | Gum arabic | / | Phase 3 | |
| HY-115870 | AZD8154 | Inhibitor | 99.88% | Phase 2 |
| HY-141677A | INCB059872 dihydrochloride | Inhibitor | 99.64% | Phase 2 |
| HY-141677C | INCB059872 TFA | Inhibitor | / | Phase 2 |
| HY-W016773 | 1,10-Decanediol | 99.95% | Phase 1 |
Inhibitory Antibodies
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P991424 | GSK2618960 | Inhibitor | 95.66% | Phase 2 |
| HY-P99821 | Ravagalimab | Inhibitor | 99.31% | Phase 2 |
| HY-P99809 | Quavonlimab | Inhibitor | ≥99.0% | Phase 2 |
| HY-P991566 | KD6001 | Inhibitor | / | Phase 2 |
| HY-P991952 | ADU-1604 | Inhibitor | / | Phase 1 |
| HY-P991961 | REGN4659 | Inhibitor | / | Phase 1 |
| HY-P991366 | IBI-397 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(28)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-148980A | Polyinosinic acid sodium | 91.5% | Unkown | |
| HY-150749A | ODN D-SL03 sodium | 98.57% | Unkown | |
| HY-163962 | L18I | 99.89% | Unkown | |
| HY-141677 | INCB059872 | Inhibitor | 99.88% | Unkown |
| HY-138794B | XL177B | 99.36% | Unkown | |
| HY-150749 | ODN D-SL03 | Inducer | 99.82% | Unkown |
| HY-N10116A | Calamenene | / | Unkown | |
| HY-148980 | Polyinosinic acid | / | Unkown | |
| HY-141677B | INCB059872 tosylate | Inhibitor | / | Unkown |
| HY-143410 | Anti-inflammatory agent 16 | Inhibitor | / | Unkown |
| HY-144675 | LSD1-IN-13 | Inhibitor | / | Unkown |
| HY-144675A | LSD1-IN-13 hydrochloride | Inhibitor | / | Unkown |
| HY-150740 | ODN 21595 | Inhibitor | / | Unkown |
| HY-152201 | BTK-IN-18 | Inhibitor | / | Unkown |
| HY-160227 | ORN 06 | Activator | / | Unkown |
| HY-161833 | HSP90-IN-31 | Inhibitor | / | Unkown |
| HY-169819 | Calcium influx inducer compound 634 | / | Unkown | |
| HY-170403 | LSD1-IN-38 | Inhibitor | / | Unkown |
| HY-173070 | TLR7 agonist 29 | / | Unkown | |
| HY-179336 | TLR7/8 agonist 14 | / | Unkown | |
| HY-181781 | LSD1-IN-48 | / | Unkown | |
| HY-RS02274 | CD86 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W016773S | 1,10-Decanediol-d20 | / | Unkown | |
| HY-150740A | ODN 21595 sodium | Inhibitor | / | Unkown |
| HY-168384 | M04 | / | Unkown | |
| HY-184441 | CD28-IN-4 | Inhibitor | / | Unkown |
| HY-RS16645 | Cd86 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23079 | Cd86 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990260 | Anti-Mouse CD86/B7-2 Antibody (GL-1) | Inhibitor | 99.17% | Unkown |
| HY-P990127 | Anti-Mouse CD80/B7-1 Antibody (RM80) | Inhibitor | 95% | Unkown |
| HY-P990261 | Anti-Mouse CD83 Antibody (Michel-17) | Inhibitor | 98.722% | Unkown |
| HY-P991759 | Anti-Rat CD86 Antibody (OX-48) | Inhibitor | / | Unkown |
| HY-P991777 | Anti-Mouse CD86/B7-2 Antibody (2D10) | Inhibitor | / | Unkown |
| HY-P991908 | Anti-CD86 Antibody (3D1) | / | Unkown | |
| HY-P991918 | KHK2840 | Agonist | / | Unkown |
| HY-P992408 | MEDI-5083 | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service